Soleno Therapeutics Inc header image

Soleno Therapeutics Inc

SLNO

Equity

ISIN null / Valor 121339545

NASDAQ (2025-11-21)

USD 45.11+0.36%

Soleno Therapeutics Inc
UMushroom community rating:

4.14 8 votes No rating yet

NegativeNeutralPositive

About company

Soleno Therapeutics Inc. is a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative treatments for rare diseases. The company's primary focus is on its lead candidate, DCCR (Diazoxide Choline) Extended-Release tablets, which are designed as a once-daily oral treatment for Prader-Willi syndrome (PWS), a complex genetic disorder. Currently, DCCR is undergoing evaluation in a Phase 3 clinical development program. Soleno aims to address unmet medical needs by providing safe and effective therapeutic solutions that enhance the quality of life for patients with life-threatening rare conditions.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-17.4%1Y

4,116%3Y

51.1%5Y

Performance

65.2%1Y

136%3Y

120%5Y

Volatility

2397 M

Market cap (USD)

1,312,507

Daily traded volume (Shares)

45.46 / 43.99

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

4.14

8 votes

Performance:

4.06

Innovation:

4.14

Society:

3.84

Nature:

3.86

Yiling Guo

United Kingdom, 09 Nov 2025

Good financial performance and under valued

Aditya Jain

United Kingdom, 09 Nov 2025

Good

Meruert Daniyarkyzy

United Kingdom, 09 Nov 2025

Volatile and high risk, but offers notable upside potential if its lead treatment succeeds.

EQUITIES OF THE SAME SECTOR

Edwards Lifesciences Corp

Edwards Lifesciences Corp Valor: 1065343

Annual Return

-50%0%+50%

Risk level

110

1.24%USD 85.13

Dyne Therapeutics Inc

Dyne Therapeutics Inc Valor: 56806425

Annual Return

-50%0%+50%

Risk level

110

5.27%USD 21.18

Boiron SA

Boiron SA Valor: 487646

Annual Return

-50%0%+50%

Risk level

110

0.95%EUR 26.60

Bright Horizons Family Solutions

Bright Horizons Family Solutions Valor: 19920287

Annual Return

-50%0%+50%

Risk level

110

3.62%USD 101.12

Dr Reddy'S Laboratories Ltd

Dr Reddy'S Laboratories Ltd Valor: 1221723

Annual Return

-50%0%+50%

Risk level

110

0.07%USD 13.91

SCHOTT Pharma AG & Co. KGaA

SCHOTT Pharma AG & Co. KGaA Valor: 128964250

Annual Return

-50%0%+50%

Risk level

110

0.66%EUR 18.44

Coloplast A/S

Coloplast A/S Valor: 20259063

Annual Return

-50%0%+50%

Risk level

110

0.55%DKK 580.20

MannKind Corp

MannKind Corp Valor: 35935511

Annual Return

-50%0%+50%

Risk level

110

1.21%USD 5.03

Essity AB

Essity AB Valor: 36851944

Annual Return

-50%0%+50%

Risk level

110

1.79%SEK 260.90

Lifco Ab

Lifco Ab Valor: 111355378

Annual Return

-50%0%+50%

Risk level

110

-0.18%SEK 342.20

SIX

FactSet

Clearbit

Logos provided by Clearbit